PEDIATRICS Vol. 111 No. 1 January 2003, pp. 179-185
REVIEW ARTICLE |
Does Stimulant Therapy of Attention-Deficit/Hyperactivity Disorder Beget Later Substance Abuse? A Meta-analytic Review of the Literature
* Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, Massachusetts
Harvard Medical School, Boston, Massachusetts
--> Objective.Concerns exist that stimulant therapy of youths with attention-deficit/hyperactivity disorder (ADHD) may result in an increased risk for subsequent substance use disorders (SUD). We investigated all long-term studies in which pharmacologically treated and untreated youths with ADHD were examined for later SUD outcomes.
Methods.A search of all available prospective and retrospective studies of children, adolescents, and adults with ADHD that had information relating childhood exposure to stimulant therapy and later SUD outcome in adolescence or adulthood was conducted through PubMed supplemented with data from scientific presentations. Meta-analysis was used to evaluate the relationship between stimulant therapy and subsequent SUD in youths with ADHD in general while addressing specifically differential effects on alcohol use disorders or drug use disorders and the potential effects of covariates.
Results.Six studies—2 with follow-up in adolescence and 4 in young adulthood—were included and comprised 674 medicated subjects and 360 unmedicated subjects who were followed at least 4 years. The pooled estimate of the odds ratio indicated a 1.9-fold reduction in risk for SUD in youths who were treated with stimulants compared with youths who did not receive pharmacotherapy for ADHD (z = 2.1; 95% confidence interval for odds ratio [OR]: 1.1–3.6). We found similar reductions in risk for later drug and alcohol use disorders (z = 1.1). Studies that reported follow-up into adolescence showed a greater protective effect on the development of SUD (OR: 5.8) than studies that followed subjects into adulthood (OR: 1.4). Additional analyses showed that the results could not be accounted for by any single study or by publication bias.
Conclusion.Our results suggest that stimulant therapy in childhood is associated with a reduction in the risk for subsequent drug and alcohol use disorders.
Key Words: attention-deficit/hyperactivity disorder • substance use • pharmacotherapy
Abbreviations: ADHD, attention-deficit/hyperactivity disorder • SUD, substance use disorders • OR, odds ratio • POR, precision of the odds ratio • SN, standard normal deviate • CI, confidence interval
Received for publication Jan 17, 2002; Accepted Jun 18, 2002.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Halmoy, O. B. Fasmer, C. Gillberg, and J. Haavik Occupational Outcome in Adult ADHD: Impact of Symptom Profile, Comorbid Psychiatric Problems, and Treatment: A Cross-Sectional Study of 414 Clinically Diagnosed Adult ADHD Patients J Atten Disord, September 1, 2009; 13(2): 175 - 187. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Setlik, G. R. Bond, and M. Ho Adolescent Prescription ADHD Medication Abuse Is Rising Along With Prescriptions for These Medications Pediatrics, September 1, 2009; 124(3): 875 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kim, M. A. Teylan, M. Baron, A. Sands, A. C. Nairn, and P. Greengard Methylphenidate-induced dendritic spine formation and {Delta}FosB expression in nucleus accumbens PNAS, February 24, 2009; 106(8): 2915 - 2920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Modesto-Lowe, J. S. Danforth, and D. Brooks ADHD: Does Parenting Style Matter? Clinical Pediatrics, November 1, 2008; 47(9): 865 - 872. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Wilens, J. Adamson, M. C. Monuteaux, S. V. Faraone, M. Schillinger, D. Westerberg, and J. Biederman Effect of Prior Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder on Subsequent Risk for Cigarette Smoking and Alcohol and Drug Use Disorders in Adolescents Arch Pediatr Adolesc Med, October 1, 2008; 162(10): 916 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Kollins ADHD, Substance Use Disorders, and Psychostimulant Treatment: Current Literature and Treatment Guidelines J Atten Disord, September 1, 2008; 12(2): 115 - 125. [Abstract] [PDF]
|
|
|
|
 |
|
 B. H. Levine and R. C. Albucher Patient Management Exercise Child and Adolescent Psychiatry Focus, July 1, 2008; 6(3): 299 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Biederman, M. C. Monuteaux, T. Spencer, T. E. Wilens, H. A. MacPherson, and S. V. Faraone Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study Focus, July 1, 2008; 6(3): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Focus, July 1, 2008; 6(3): 401 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Swanson, L. E. Arnold, H. Kraemer, L. Hechtman, B. Molina, S. Hinshaw, B. Vitiello, P. Jensen, K. Steinhoff, M. Lerner, et al. Evidence, Interpretation, and Qualification From Multiple Reports of Long-Term Outcomes in the Multimodal Treatment Study of Children With ADHD (MTA): Part II: Supporting Details J Atten Disord, July 1, 2008; 12(1): 15 - 43. [Abstract] [PDF]
|
|
|
|
 |
|
 N. D. Volkow and J. M. Swanson Does Childhood Treatment of ADHD With Stimulant Medication Affect Substance Abuse in Adulthood? Am J Psychiatry, May 1, 2008; 165(5): 553 - 555. [Full Text] [PDF]
|
|
|
|
|
|
J. Biederman, M. C. Monuteaux, T. Spencer, T. E. Wilens, H. A. MacPherson, and S. V. Faraone Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study Am J Psychiatry, May 1, 2008; 165(5): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. McCabe Screening for Drug Abuse Among Medical and Nonmedical Users of Prescription Drugs in a Probability Sample of College Students Arch Pediatr Adolesc Med, March 1, 2008; 162(3): 225 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Arnold, R. L. Lindsay, F. A. Lopez, S. E. Jacob, J. Biederman, R. L. Findling, and Y. Ramadan Treating Attention-Deficit/Hyperactivity Disorder With a Stimulant Transdermal Patch: The Clinical Art Pediatrics, November 1, 2007; 120(5): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Reference List for FOCUS Self-Assessment Examination PsychiatryOnline CME, October 10, 2007; 2007(3): 2 - 2. [Full Text]
|
|
|
|
 |
|
 N. D. Volkow, G.-J. Wang, J. Newcorn, F. Telang, M. V. Solanto, J. S. Fowler, J. Logan, Y. Ma, K. Schulz, K. Pradhan, et al. Depressed Dopamine Activity in Caudate and Preliminary Evidence of Limbic Involvement in Adults With Attention-Deficit/Hyperactivity Disorder Arch Gen Psychiatry, August 1, 2007; 64(8): 932 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Advokat Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD J Atten Disord, July 1, 2007; 11(1): 8 - 16. [Abstract] [PDF]
|
|
|
|
|
|
T. R. Kosten and T. A. Kosten New Medication Strategies for Comorbid Substance Use and Bipolar Affective Disorders Focus, January 1, 2007; 5(2): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, K. A. Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology J Psychopharmacol, January 1, 2007; 21(1): 10 - 41. [Abstract] [PDF]
|
|
|
|
|
|
H. Ashton, P. Gallagher, and B. Moore The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder J Psychopharmacol, September 1, 2006; 20(5): 602 - 610. [Abstract] [PDF]
|
|
|
|
|
|
T. E. Wilens, J. B. Prince, T. J. Spencer, and J. Biederman Stimulants and Sudden Death: What Is a Physician to Do? Pediatrics, September 1, 2006; 118(3): 1215 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ernst, D. A. Luckenbaugh, E. T. Moolchan, M. K. Leff, R. Allen, N. Eshel, E. D. London, and A. Kimes Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics, June 1, 2006; 117(6): 2030 - 2039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P Gibson, T. L Bettinger, N. C Patel, and M L. Crismon Atomoxetine Versus Stimulants for Treatment of Attention Deficit/Hyperactivity Disorder Ann. Pharmacother., June 1, 2006; 40(6): 1134 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sood, D. L. Barton, and C. L. Loprinzi Use of methylphenidate in patients with cancer American Journal of Hospice and Palliative Medicine, January 1, 2006; 23(1): 35 - 40. [Abstract] [PDF]
|
|
|
|
 |
|
 J. A. Dopheide ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients Am. J. Health Syst. Pharm., July 15, 2005; 62(14): 1502 - 1509. [Full Text] [PDF]
|
|
|
|
 |
|
 C R Steer Managing attention deficit/hyperactivity disorder: unmet needs and future directions Arch. Dis. Child., February 1, 2005; 90(suppl_1): i19 - i25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Rappley Attention Deficit-Hyperactivity Disorder N. Engl. J. Med., January 13, 2005; 352(2): 165 - 173. [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. S. Voeller Attention-Deficit Hyperactivity Disorder (ADHD) J Child Neurol, October 1, 2004; 19(10): 798 - 814. [Abstract] [PDF]
|
|
|
|
 |
|
 T. E. Wilens, S. V. Faraone, and J. Biederman Attention-Deficit/Hyperactivity Disorder in Adults JAMA, August 4, 2004; 292(5): 619 - 623. [Full Text] [PDF]
|
|
|
|
 |
|
 P. S Jensen Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder Evid. Based Med., November 1, 2003; 8(6): 188 - 188. [Full Text] [PDF]
|
|
|
|
|
|
Selections from Journal Watch Pediatrics and Adolescent Medicine Arch. Dis. Child., August 1, 2003; 88(8): 740 - 741. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Weiss and C. Murray ADHD and driving safety Can. Med. Assoc. J., July 8, 2003; 169(1): 16 - 16. [Full Text] [PDF]
|
|
|
|
 |
|
 OTHER ARTICLES NOTED (24 Jan 03 to 18 Apr 03) Evid. Based Nurs., July 1, 2003; 6(3): e1 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 Stimulants for ADHD: Do They Lead to Substance Abuse? Journal Watch Dermatology, March 26, 2003; 2003(326): 14 - 14. [Full Text]
|
|
|
|
|
|
M. Weiss and C. Murray Assessment and management of attention-deficit hyperactivity disorder in adults Can. Med. Assoc. J., March 18, 2003; 168(6): 715 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Is Stimulant Therapy for ADHD Linked with Later Substance Abuse? Journal Watch Pediatrics and Adolescent Medicine, February 10, 2003; 2003(210): 6 - 6. [Full Text]
|
|
|
|
 |
|
 Stimulants for ADHD: Do They Lead to Substance Abuse? Journal Watch (General), February 4, 2003; 2003(204): 4 - 4. [Full Text]
|
|
